| Serial Number | 97809052 |
| Word Mark | DAXXIFY |
| Filing Date | Thursday, February 23, 2023 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Tuesday, August 27, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 2, 2024 |
| Goods and Services | Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; Dermatological pharmaceutical products and pharmaceutical preparations injected into or under the skin, into or under mucous membranes for filling in wrinkles, skin depressions for remodeling, increasing volume in the face or any other part of the body, for moisturizing the skin or mucous membranes, for increasing lip volume |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 14, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Revance Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Newark, CA 94560 |
| Party Name | Revance Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Newark, CA 94560 |
| Event Date | Event Description |
| Monday, February 27, 2023 | NEW APPLICATION ENTERED |
| Tuesday, March 14, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, November 21, 2023 | ASSIGNED TO EXAMINER |
| Monday, November 27, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, January 2, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, January 2, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, December 13, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 27, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, August 27, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, August 27, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, August 27, 2024 | SOU EXTENSION 1 FILED |
| Tuesday, August 27, 2024 | SOU EXTENSION 1 GRANTED |